As of Q1 2025, Chinas rehabilitation medical equipment import scale exceeded $8.2 billion, with a compound annual growth rate of 9.3%. Among them, neurological rehabilitation robots and intelligent rehabilitation training systems (Class II) accounted for 47%, while the approval rate for Class III active treatment equipment imports decreased by 12 percentage points compared to 2022. The market shows three significant characteristics:Medical EquipmentRegulatory hierarchy refinement:
Customs added 7 new functional parameter testing standards for rehabilitation equipmentTrade model transformation:
Bonded maintenance business volume increased by 210% year-on-yearService demand upgrade:
81% of importers require agents to have clinical verification support capabilitiesCore process analysis of the complete import procedure
Taking the import of lower limb rehabilitation robots from Germany as an example, professional agency services need to control the following key nodes:
Confirm HS code (200) and medical device registration classification
Pre - classification stage
Verify the matching degree between EU MDR certification and domestic type inspection reports
Logistics planning phase
Precision instruments require constant temperature and humidity containers (temperature error ±2℃)
Configure packaging solutions with anti-vibration levels reaching ISTA 3A
Prepare the Imported Medical Device Registration Certificate and clinical evaluation report
Customs declaration phase
The equipment software version number (V2.3.5 or above) must be specified during declaration
Four-dimensional risk prevention management model
Professional agency service providers should establish the following prevention mechanisms:
Intervene in product design improvements 6 months in advance
Used equipment needs to provide the Maintenance Record from the Japanese original factory
Establish a traceability database for key components
Establish key component traceability database
Compliance risk control
Dynamic monitoring of regulatory updates in 28 countries/regions
Establish a label management system (supports 11 language conversions)
Financial risk control
Use NDF tools to hedge against exchange rate fluctuations
Six key tips for selecting agency service providers
Based on 2025 industry research data, quality agencies should possess:
≥120 cases of medical device imports
Familiarity with special customs clearance requirements at 8 major ports
Capability for overseas factory inspections (covering EU/North America/Asia-Pacific)
Own bonded warehouses (area ≥3000㎡)
Professional legal team (handled ≥15 quality disputes)
Provide equipment calibration services (compliant with JJF 1478-2024 standard)
Under the current trend of stricter import regulations, selecting full-chain service agency partners can improve customs clearance efficiency by 40% and reduce overall costs by 18%-22%. Importers are advised to focus on three core capabilities: technical document processing, quality system integration experience, and post-sales dispute resolution mechanisms.